Author:
Wilson Erin C.,Turner Caitlin M.,Sanz-Rodriguez Christina,Arayasirikul Sean,Gagliano Jayne,Woods Tiffany,Palafox Erika,Halfin Janet,Martinez Lorena,Makoni Bessa,Eskman Zebediah,Lin Royce,Rodriguez Esteban,Rapues Jenna,Pardo Seth,Liu Albert
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Pharmacology (medical),Infectious Diseases
Reference28 articles.
1. PrEP uptake and discontinuation among a U.S. National sample of transgender men and women;Zarwell;AIDS Behav,2020
2. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco;Liu;PLoS Med.,2014
3. FDA approves first drug to prevent HIV infection;Roehr;BMJ,2012
4. Knowledge, indications and willingness to take pre-exposure prophylaxis among transwomen in San Francisco, 2013;Wilson;PLoS One,2015
5. Disparities in the PrEP continuum for trans women compared to MSM in San Francisco, California: results from population-based cross-sectional behavioural surveillance studies;Wilson;J Int AIDS Soc.,2020
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献